FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk A/S ... Jorgensen will continue as CEO “for a period” to support a smooth transition. AP Health Writer Tom Murphy ...

This transition reflects a planned and strategic evolution of MC2 Therapeutics, aligned with the company’s focus on commercial expansion.

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow's standard-of-care to cure cancer and infectious diseases, is honored to share that it was awarded ...

In an effort to maximize the earnings potential of its plaque psoriasis cream, Danish dermatology biotech MC2 Therapeutics ...

As previously announced, Kathryn Leaf has assumed the role of Chief Executive Officer, while Jeff Miller is now Chief Investment Officer. Kathryn and Jeff both joined Pantheon in 2008, and most ...

MotorTrend's Ed Loh & Jonny Lieberman sit down with President & CEO of Mercedes-Benz North America ... and how to balance the transition to the Software Defined Vehicle era!